Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Panbela Provides Business Update and Reports Q3 2024 Financial Results
-
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
-
Acadia Healthcare (ACHC) Class Period Expanded After NYT Report That Veterans Affairs Department Is Investigating Allegations of Holding Patients Longer Than Is Medically Necessary - Hagens Berman
-
Greenland Reports 75.3% Increase in Net Income for First Nine Months of 2024
-
The Home Depot Declares Third-Quarter Dividend of $2.25
-
Eastside Distilling Reports Third Quarter 2024 Financial Results
-
VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update
-
STANDEX ACQUIRES CUSTOM BIOGENIC SYSTEMS
-
Sherwin-Williams Executive Chairman John Morikis to Retire; President and CEO Heidi Petz Elected Chair
-
Curacao Kicks Off the Holidays with Exceptional Savings Throughout Month-Long Black Friday Sales Event
-
Fundamental Global Inc. Reports Third Quarter 2024 Financial Results
-
Motorsport Games Reports Third Quarter 2024 Financial Results
-
BC First Nations Justice Council Receives Funding from Public Safety Canada for Innovative Pre-Charge Diversion Program in Lheidli T’enneh Territory (Prince George, BC)
-
flyExclusive Reports Third Quarter 2024 Financial Results
-
Avista Corp. Board Declares Common Stock Dividend
-
Safe Pro Group Reports 102% Revenue Growth in Third Quarter 2024
-
JOHN HANCOCK CLOSED-END FUNDS RELEASE EARNINGS DATA
-
Unusual Machines Issues Letter to Shareholders
-
Harte Hanks Reports Third Quarter 2024 Results
-
Ucore Closes Private Placement Financing
-
Burcon Announces Fiscal 2025 Second Quarter Results
-
Monogram Technologies Reports Third Quarter 2024 Financial Results
-
GameSquare Holdings Reports Record 2024 Third Quarter Results
-
Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital
-
Rocky Mountain Chocolate Factory Announces the Opening of Two New Store Locations and Kiosk
-
TILT Holdings Reports Third Quarter 2024 Results and Announces Strategic Review of its Plant-Touching Business
-
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics
-
Thunder Power Reports Unaudited Third Quarter 2024 Financial Results
-
Artera Celebrates Executive Promotions and Multiple New Industry Accolades
-
Canadian North Resources Inc. Announces Appointment Of Henderson Tse To The Board Of Directors
-
Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
-
iPower Reports Fiscal First Quarter 2025 Results
-
Alumis Presents Data Highlighting ESK-001’s Potential as a High-efficacy Oral Treatment for Systemic Lupus Erythematosus (SLE) at ACR Convergence 2024
-
UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting
-
T2 Biosystems Announces Third Quarter 2024 Financial Results
-
Aqua Metals Announces Progress on Operational Achievements and Ongoing Commercial Development, Reports Third Quarter 2024 Results
-
Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference
-
Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update
-
Rekor Systems Reports Third Quarter 2024 Financial Results
-
Senti Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights
-
Vuzix Reports Third Quarter 2024 Results
-
Perimeter Medical Imaging AI Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
BioLife Solutions Announces $6.1 million Sale of its Custom Biogenic Systems Freezer Subsidiary
-
INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights
-
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Third Quarter and Year to Date 2024 Financial Results and Provides Business Update
-
Research Solutions Reports Fiscal First Quarter 2025 Results
-
Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025
-
4Front Ventures Reports Third Quarter 2024 Results
-
Perfect Moment Reports Fiscal Q2 2025 Results
-
Starco Brands Reports Third Quarter 2024 Financial Results

